Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) today announced the pricing of an underwritten public offering of 11,670,000 ordinary shares at a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE